Navigation Links
CEL-SCI Scientist Invited to Discuss Plans to Launch Unique Manufacturing Process That Saves Cost While Enhancing the Shelf Life of Drugs at 5th Annual Aseptic Processing of Sterile Drug Products Conference
Date:6/16/2009

VIENNA, Va., June 16 /PRNewswire-FirstCall/ -- CEL-SCI Corporation (NYSE Amex: CVM) announced today that Eyal Talor, Ph.D., Senior Vice President of Research and Manufacturing at CEL-SCI, has accepted an invitation to be a featured speaker at the 5th Annual Aseptic Processing of Sterile Drug Products Conference to be held June 17th - 19th. The Conference, sponsored by The Institute of Validation Technology (IVT), takes place at the Sheraton National Hotel in Arlington, VA. At the workshop titled "Aseptic Facility Design Fundamentals - Cold Fill/Finish Design for a Biologic, Liquid Injectable", Dr. Talor will discuss the Company's plans to launch a unique manufacturing process that could allow drugs using stem cell technology and other biological products to maintain their potency through the entire manufacturing process, as well as enhance the shelf life of these drugs.

The availability of this unique aseptic filling process developed by CEL-SCI may also significantly accelerate the time to market by eliminating complicated, costly and time consuming validation studies and tests required when these products are filled at room temperature. This process is also likely to save money in the production of follow-on biologics and biosimilars (the general equivalent of generics in the biological arena) likely to be approved in the U.S. soon.

CEL-SCI's new state-of-the-art manufacturing facility near Baltimore, Maryland, where CEL-SCI plans to manufacture its lead cancer product Multikine(R), will be offering this service to outside companies on a contract basis. The facility will allow CEL-SCI to perform aseptic filling of small volume parenteral drug products.

The Company will employ a process known as "true cold" +4 degrees Celsius Aseptic Filling for products derived from stem cell technology, biotechn
'/>"/>

SOURCE CEL-SCI Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. CEL-SCI Expands Testing of Its Vaccine to Determine Efficacy Against More Virulent Strain of H1N1 Swine and Other Influenza Viruses
2. CEL-SCI Corporation Reports 2009 Second Fiscal Quarter Financial Results
3. CEL-SCI Announces Exclusive Licensing Agreement for Cancer Drug Multikine(R) for Republic of South Africa
4. CEL-SCI Launches Study to Determine Long Lasting Beneficial Effects of its Rheumatoid Arthritis Vaccine
5. CEL-SCI Presents Favorable Data for Leaps Vaccine Technology at Prestigious Immunology Conference
6. CEL-SCI Corporation Reports Second Quarter 2008 Financial Results
7. CEL-SCI CORPORATION Announces Results of 2008 Annual Meeting of Shareholders and Provides Update on Ground-breaking Activities Regarding Construction of Manufacturing Facility for Pivotal Phase III Cancer Trial
8. CEL-SCI Corporation Releases Letter to Shareholders
9. CEL-SCI Corporation Announces Adoption of Shareholder Rights Plan
10. Comprehensive Review of Cancer Immnunotherapies Published By CEL-SCI
11. Scientists advance safety of nanotechnology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... The leading retail brand Short Dresses ... prom dresses . Now that is quite unbelievable, especially in ... brand name since its origin. The retailer has already revealed ... this huge discount offer will be an added bonanza for ... privileged to announce that Short Dresses is to offer different ...
(Date:5/23/2013)... NY (PRWEB) May 24, 2013 Magnatag’s ... employee absentee patterns and reduces vacation conflicts. A Manufacturing ... problem with vacation conflicts; now employees and managers can ... have any problems. Attendance is important to us and ... are exposed. That may seem harsh but it has ...
(Date:5/23/2013)... May 24, 2013 Sublime Beauty® ... Cellulite Whisperer line, with a 35% discount ... Sale" includes two proprietary products, the Cellulite ... . , Purchasers receive a report "Getting Control ... Gel has a wonderful grapefruit scent," says Kathy ...
(Date:5/23/2013)... -- High blood glucose is associated with poor outcomes ... (IIT) to control hyperglycemia is a common practice in ... consistent benefit and even shows harms associated with the ... Physicians, (ACP) Clinical Guidelines Committee in a new evidence-based ... of Medical Quality . , "Clinicians caring for hospitalized ...
(Date:5/23/2013)... (PRWEB) May 23, 2013 Whether working ... Operations Forces and law enforcement need an added layer ... Security Enhancer, Night VISER , is an effective ... motion sensing system to increase border and perimeter security. ... VISER have more than tripled over the past three ...
Breaking Medicine News(10 mins):Health News:short prom dresses Offers Abnormally Low Discount on Its New Collections 2Health News:New Attendance, Vacation and Training Tracker Board Reduces Employee Conflicts and Improves Attendance 2Health News:Fresh Organics in the New Cellulite Whisperer® Products from Sublime Beauty®; "Get Ready for Summer Sale" Continues 2Health News:ACP issues recommendations for management of high blood glucose in hospitalized patients 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 2Health News:Lighting Up the Night: ARA Announces Record Sales of Its Night VISER System 3
... , This release is available in German . ... encoding data at a rate of 26 terabits per second on ... km, and decoding them successfully. This is the largest data volume ... allows to transmit the contents of 700 DVDs in one second ...
... Mount Sinai School of Medicine have discovered a protein signaling ... medications to inhibit this pathway may be effective in the ... the current issue of the journal Cancer Cell . ... Jack and Jane B. Aron Professor and Chairman of the ...
... a number from the University of North Carolina at Chapel ... that contribute to the debilitating lung disease that is the ... into the causes of the wide variation in lung disease ... to new diagnostic markers and therapeutic approaches for this and ...
... , SUNDAY, May 22 (HealthDay News) -- New Swedish ... of major cardiovascular complications among patients who have ... finding builds on earlier work that was published by ... fall. That study suggested that Inspra (eplerenone), an aldosterone ...
... has found that allowing full access to personal medical ... cancer patients. Published early online in Cancer , ... study indicates that providing accurate information to patients through ... communication with their physicians. Most cancer patients say ...
... Hospital for Special Surgery in New York has shown that ... suppress aspects of inflammation. The researchers say the identification of ... new treatments for diseases such as rheumatoid arthritis. The study ... the journal Nature Immunology . "Prior to this ...
Cached Medicine News:Health News:World record in ultra-rapid data transmission 2Health News:Mount Sinai researchers discover possible new target for sarcoma treatment and prevention 2Health News:Consortium identifies genome regions that could influence severity of cystic fibrosis 2Health News:Consortium identifies genome regions that could influence severity of cystic fibrosis 3Health News:Blood Pressure Drug Helps Those With Mild Heart Failure 2Health News:Access to personal medical records increases satisfaction among new cancer patients 2Health News:Study identifies novel role for a protein that could lead to new treatments for rheumatoid arthritis 2Health News:Study identifies novel role for a protein that could lead to new treatments for rheumatoid arthritis 3
(Date:5/23/2013)... 23, 2013  Spring Bank Pharmaceuticals, Inc., a biopharmaceutical ... infections, today announced that it has initiated dosing in ... once daily, oral therapy for the treatment of HCV ... and is designed to assess both the safety and ... first-in-class drug for the treatment of chronic HCV infections ...
(Date:5/23/2013)... FREDERICK, Md. , May 23, 2013  BioElectronics ... safe consumer medical devices, comments on the FDA panel ... Public Advisory Panel Reclassification – Pulsed Shortwave Therapy Meeting ... Gaithersburg, MD , USA.  The focus of the ... instructed the panel to focus solely on the application ...
(Date:5/23/2013)... , May 23, 2013 Halozyme Therapeutics, ... the appointment of David A. Ramsay ... was most recently Vice President, Corporate Development at ... "With his established financial management experience ... by working in our commercial group for the ...
Breaking Medicine Technology:Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 2Spring Bank Pharmaceuticals Initiates a Phase I Clinical Trial for SB 9200 in HCV-infected Patients 3BioElectronics and Pulsed Shortwave Therapy Make Progress 2Halozyme Therapeutics Names David A. Ramsay Chief Financial Officer 2
... (Nasdaq: KNDL ), a leading, global full-service ... its Annual Meeting of Shareholders due to its merger ... been scheduled for May 19, 2011, in Cincinnati, Ohio. ... a merger agreement with INC Research.  The merger transaction ...
... A new device designed to assist blood circulation ... coronary intervention (PCI) has shown improved outcomes compared to ... of the PROTECT II study were presented as a ... Sessions in Baltimore. These devices decrease ...
Cached Medicine Technology:Kendle Announces Postponement of 2011 Annual Meeting 2Kendle Announces Postponement of 2011 Annual Meeting 3Kendle Announces Postponement of 2011 Annual Meeting 4New Device to Support Blood Circulation for Heart Patients Shows Improved Outcomes Compared to Current Treatment 2
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: